Systems Oncology retweeted
Bispecific #Aptamer Chimeras Enable Targeted Protein Degradation on Cell Membranes
@SassStem @Giangran1Paloma @AptamerSociety @aptamer_connect @BurkeLabRNA @HTSohLab
@mallikaratchy @Bluebird__47 @hocekm @MariaCDeRosa
@bionaloo @AshPMenon @koudrina
pubmed.ncbi.nlm.nih.gov/3363…
Congressman @DavidSchweikert visited the @SystemsOncology's laboratories today.
There is still an unmet need for patients who progress on all current breast cancer treatment options. This new next-generation SERA compound has proven to have outstanding efficacy and tolerability, which is a strong indicator that SERA2 should produce... shorturl.at/anxEJ
Our CEO, @smousses, presented at the BMO Fall Life Science Private Company Showcase. To watch him speak about our multimodal RNA therapeutic platform, click here: https://xitter.cf/t.co/TWX8t6NeTq
#innovation #drugdevelopment
3
1
This Thursday our CEO, Spyro Mousses, will be speaking about how @SystemsOncology is revolutionizing cancer therapies through our multimodal RNA therapeutic platform, Arromer! He will be speaking from 12:20-12:50pm EDT - click here for more info: https://xitter.cf/t.co/8pUljCVKcI
1
1
Next week our CEO, @smousses, will be presenting at Tides. He will be speaking about how @SystemsOncology is revolutionizing cancer therapies through our multimodal RNA therapeutic platform, Arromer. Click here for more info: https://xitter.cf/t.co/axwCoIRIO7
1
Our CEO, @smousses, spoke at the H.C. Wainwright & Co., 23rd Annual Global Investment Conference. Click here to view his presentation: https://xitter.cf/t.co/JTxmIxiNG0
#innovation #oncology #drugdevelopment
1
Systems Oncology to Present at Upcoming Scientific and Investor Conferences - click here: bwnews.pr/2WWyD1w
Meet our Scientific Innovation Manager, Madeline Sell. Madeline evaluates institutional acquisition opportunities using patent-driven searches, literature reviews, and investigation of academic start-ups. @SystemsOncology appreciates you, Madeline!
1
Today at @SystemsOncology, Dr. Marvin O’ketch performed a small molecule drug screening using our ECHO 650 Acoustic Dispenser.
#innovation #oncology #drugdevelopment
Meet Lizette Castano! She is a graduate from @seattleu with a degree in cellular and molecular biology - we are thankful to have you, Lizette.
#innovation #oncology #internship
1
Meet our Research Associate III, Ioanna Papacharalampous. She is producing RNA using in vitro transcription. The RNA produced will be used in testing our multimodal therapeutic platform, Arromer!
#innovation #oncology #drugdevelopment
Katy Marhenke joined us fresh out of college and has now been promoted to our Director of Business Development Operations. We are thankful to have you, Katy!
2
We love seeing our employees accomplishing goals outside of work. Congrats to our lab manager, David Lee on your golf achievements!
#innovation #inspiration
1
Meet one of our R&D interns, Paris Offer. During her time here at @SystemsOncology, she will be working on sorting and researching therapeutic targets. We are thankful to have you, Paris.
#innovation #oncology #drugdevelopment
1
July is bone and sarcoma awareness month! This is an uncommon form of cancer that is mostly diagnosed in teenagers. Click here to read more from the @AACR: https://xitter.cf/t.co/BtIOc2mRvX
#innovation #oncology #drugdevelopment
1
Happy 4th of July! Today we celebrate the land of the free because of the brave. We wish everyone a safe and relaxing holiday weekend!
1
We are excited to welcome our new Research Associate III, Nathalie Azorsa. Nathalie graduated from @uarizona with a BS in Molecular and Cellular Biology. Before joining us, she previously worked in laboratories in the Departments of Pharmacology and Child Health.
3















